Finance

Lists
002728:SHE
Teyi Pharmaceutical Group Co Ltd
9,65 CNY
-0,72%
(-0,070) 1D
16 ოქტ, 15:04:54 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002728...
Open
9,69 CNY
High
10,20 CNY
Low
9,60 CNY
Mkt. cap
4,99 მლრდ.
Avg. vol.
19,12 მლნ.
Volume
31,46 მლნ.
Dividend
1,55%
Quarterly dividend
0,04 CNY
Ex-dividend date
18 ივნ. 2026
P/E ratio
69,16
52-wk high
15,21 CNY
52-wk low
7,66 CNY
EPS
0,14 CNY
Shares outstanding
513,31 მლნ.
No. of employees
1 ათ.
Open
9,69 CNY
High
10,20 CNY
Low
9,60 CNY
Mkt. cap
4,99 მლრდ.
Avg. vol.
19,12 მლნ.
Volume
31,46 მლნ.
Dividend
1,55%
Quarterly dividend
0,04 CNY
Ex-dividend date
18 ივნ. 2026
P/E ratio
69,16
52-wk high
15,21 CNY
52-wk low
7,66 CNY
EPS
0,14 CNY
Shares outstanding
513,31 მლნ.
No. of employees
1 ათ.
News stories
From web sources and news partners
medwatch.com
medwatch.com
·
25 წუთის წინ
Iambic Therapeutics raises USD 150m in Nasdaq IPO
Yahoo Finance
Yahoo Finance
·
14 წუთის წინ
3 S&P 500 Stocks We Steer Clear Of
About Teyi Pharmaceutical Group Co Ltd
CEO-
Employees1,43 ათ.
Founded23 მაი. 2002
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
200,71 მლნ.
232,68 მლნ.
209,87 მლნ.
183,45 მლნ.
Cost of goods sold
102,58 მლნ.
123,26 მლნ.
81,88 მლნ.
87,55 მლნ.
Cost of revenue
102,58 მლნ.
123,26 მლნ.
81,88 მლნ.
87,55 მლნ.
Research and development expenses
11,06 მლნ.
14,19 მლნ.
9,25 მლნ.
11,05 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
62,18 მლნ.
83,64 მლნ.
85,27 მლნ.
75,71 მლნ.
Operating expense
73,02 მლნ.
102,76 მლნ.
93,09 მლნ.
88,23 მლნ.
Total operating expenses
175,60 მლნ.
226,01 მლნ.
174,97 მლნ.
175,78 მლნ.
Operating income
25,11 მლნ.
6,67 მლნ.
34,91 მლნ.
7,67 მლნ.
Other non operating income
-755,83 ათ.
604,89 ათ.
-33,22 ათ.
-206,21 ათ.
EBT including unusual items
26,78 მლნ.
7,45 მლნ.
35,14 მლნ.
7,17 მლნ.
EBT excluding unusual items
24,81 მლნ.
7,29 მლნ.
35,61 მლნ.
7,09 მლნ.
Income tax expense
-433,06 ათ.
-9,00 მლნ.
9,37 მლნ.
1,83 მლნ.
Effective tax rate
-1,62%
-120,80%
26,67%
25,48%
Other operating expenses
193,29 ათ.
4,17 მლნ.
-340,24 ათ.
1,34 მლნ.
Net income
27,21 მლნ.
16,45 მლნ.
25,76 მლნ.
5,34 მლნ.
Net profit margin
13,56%
7,07%
12,28%
2,91%
Earnings per share
-
-
-
-
Interest and investment income
1,03 მლნ.
601,98 ათ.
1,52 მლნ.
859,16 ათ.
Interest expense
-579,01 ათ.
-579,51 ათ.
-775,84 ათ.
-1,24 მლნ.
Net interest expenses
449,92 ათ.
22,46 ათ.
742,40 ათ.
-376,54 ათ.
Depreciation and amortization charges
-
-
-
-
EBITDA
41,20 მლნ.
24,12 მლნ.
52,36 მლნ.
26,35 მლნ.
Gain or loss from assets sale
-83,37 ათ.
68,45 ათ.
-
-802,00
AI content may include mistakes. Learn more
Google აპები